These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22533731)

  • 1. Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.
    Kang W; Li Y; Zhuang Y; Zhao K; Huang D; Sun Y
    BMC Infect Dis; 2012 Apr; 12():102. PubMed ID: 22533731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
    AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
    Woitas RP; Rockstroh JK; Beier I; Jung G; Kochan B; Matz B; Brackmann HH; Sauerbruch T; Spengler U
    AIDS; 1999 Jul; 13(11):1313-22. PubMed ID: 10449283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
    AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
    Fan XG; Liu WE; Li CZ; Wang ZC; Luo LX; Tan DM; Hu GL; Zhang Z
    Mediators Inflamm; 1998; 7(4):295-7. PubMed ID: 9792341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the NK cell pool in HIV/HCV co-infection.
    Kaczmarek DJ; Kokordelis P; Krämer B; Glässner A; Wolter F; Goeser F; Lutz P; Schwarze-Zander C; Boesecke C; Strassburg CP; Rockstroh JK; Spengler U; Nattermann J
    PLoS One; 2017; 12(4):e0174465. PubMed ID: 28380039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lomeli-Martinez SM; Valentin-Goméz E; Varela-Hernández JJ; Alvarez-Zavala M; Sanchez-Reyes K; Ramos-Solano M; Cabrera-Silva RI; Ramirez-Anguiano VM; Lomeli-Martinez MA; Martinez-Salazar SY; González-Hernández LA; Andrade-Villanueva JF
    Front Immunol; 2019; 10():1465. PubMed ID: 31316513
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
    Kushner LE; Wendelboe AM; Lazzeroni LC; Chary A; Winters MA; Osinusi A; Kottilil S; Polis MA; Holodniy M
    PLoS One; 2013; 8(4):e60387. PubMed ID: 23593207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    Berzsenyi MD; Woollard DJ; McLean CA; Preiss S; Perreau VM; Beard MR; Scott Bowden D; Cowie BC; Li S; Mijch AM; Roberts SK
    J Hepatol; 2011 Sep; 55(3):536-544. PubMed ID: 21266183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genotype and HIV coinfection affect cytokine mRNA levels in unstimulated PBMC but do not shift the T1/T2 balance.
    Lee S; Watson MW; Clark B; Flexman JP; Cheng W; French MA; Price P
    Immunol Cell Biol; 2006 Aug; 84(4):390-5. PubMed ID: 16834574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
    PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy.
    Osakwe CE; Bleotu C; Chifiriuc MC; Grancea C; Oţelea D; Paraschiv S; Petrea S; Dinu M; Băicuş C; Streinu-Cercel A; Lazăr V
    Roum Arch Microbiol Immunol; 2010; 69(1):24-34. PubMed ID: 21053781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.